NEWS
Glycode joins the Lyonbiopole Business Center
Glycode, created in 2004, is an expert in glycosylation.
The company has developed a proprietary innovative and powerful technology, GlycodExpress™, which consists of a bank of yeast strains genetically optimized for the production of recombinant therapeutic glycoproteins (antibodies, EPOs, growth factors…). These strains have been genetically glycol engineered to synthesize fully humanized N-glycans. Glycode raised 3M€ from Sofimac Partners, Octalfa, Sham and Limousin Participations.
